Dudediligence.

Glaukos Corporation

GKOSNYSE · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$96.7MSep ’24$105.5MDec ’24$106.7MMar ’25$124.1MJun ’25$133.5MSep ’25$143.1MDec ’25$150.6MMar ’26$185.6MJun ’26
Net income, by quarter
−$21.4MSep ’24−$33.6MDec ’24−$18.1MMar ’25−$19.7MJun ’25−$16.2MSep ’25−$133.7MDec ’25−$19.8MMar ’26−$18.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$294.0M$282.9M$314.7M$383.5M$507.4M
Gross profit$227.4M$213.9M$239.1M$289.5M$282.8M
Operating income−$32.9M−$82.3M−$128.7M−$122.4M−$199.6M
Net income−$49.6M−$99.2M−$134.7M−$146.4M−$187.7M
Operating cash flow$24.7M−$33.1M−$57.8M−$61.3M−$14.8M
Free cash flow−$23.1M−$63.3M−$78.0M−$67.6M−$22.5M
Cash$100.7M$119.5M$93.5M$169.6M$90.8M
Shares outstanding47.0M47.8M49.1M56.4M57.5M